Stay updated on Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Sign up to get notified when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.

Latest updates to the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no user-facing content changes.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating maintenance and potential minor content updates.SummaryDifference0.0%

- Check45 days agoChange DetectedFooter displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check74 days agoChange DetectedAdministrative updates: Revision: v3.4.2 has been added; the notice about a lapse in government funding has been removed along with Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedSite-wide notice about government funding lapse and operating status, and a page revision note (Revision: v3.4.1) were added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check88 days agoChange DetectedAdded a glossary toggle and a new label 'Last Update Submitted that Met QC Criteria'. Updated capitalization for 'No FEAR Act Data' and related labels, and changed the revision tag to 'Revision: v3.4.0' (replacing 'v3.3.4').SummaryDifference0.2%

Stay in the know with updates to Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Filgotinib Long-term Extension in Psoriatic Arthritis Clinical Trial page.